MALIGNANT GENITOURINARY TRACT NEOPLASM

MALIGNANT GENITOURINARY TRACT NEOPLASM was reported 67 times

MALIGNANT GENITOURINARY TRACT NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD19-directed Chimeric Antigen Receptor [EPC] 24 0.0024
1 Alkylating Drug [EPC] 27 0.0001
2 Programmed Death Ligand-1 Blocker [EPC] 2 0.0001
3 Melatonin Receptor Agonist [EPC] 1 0.0001
4 Radioligand Therapeutic Agent [EPC] 1 0.0001
5 Provitamin D2 Compound [EPC] 2 0.0001
6 Nonergot Dopamine Agonist [EPC] 1 0.0001
7 Topoisomerase Inhibitor [EPC] 3 0.0000
8 Thiazide-like Diuretic [EPC] 1 0.0000
9 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
10 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
11 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
12 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
13 Proteasome Inhibitor [EPC] 2 0.0000
14 BCL-2 Inhibitor [EPC] 1 0.0000
15 CD20-directed Cytolytic Antibody [EPC] 5 0.0000
16 Platinum-based Drug [EPC] 4 0.0000
17 Androgen Receptor Inhibitor [EPC] 1 0.0000
18 Integrin Receptor Antagonist [EPC] 1 0.0000
19 Interleukin-12 Antagonist [EPC] 1 0.0000
20 Interleukin-23 Antagonist [EPC] 1 0.0000
21 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
22 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
23 Calcium [EPC] 1 0.0000
24 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
25 Microtubule Inhibitor [EPC] 1 0.0000
26 Expectorant [EPC] 1 0.0000
27 Thalidomide Analog [EPC] 2 0.0000
28 Factor Xa Inhibitor [EPC] 1 0.0000
29 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
30 Corticosteroid [EPC] 4 0.0000
31 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
32 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
33 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
34 Vitamin C [EPC] 1 0.0000
35 Insulin Analog [EPC] 1 0.0000
36 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
37 Kinase Inhibitor [EPC] 1 0.0000
38 Benzodiazepine [EPC] 1 0.0000